Upcoming earnings call puts Enovis in focus Enovis (ENOV) has scheduled an investor conference call and webcast for November 5, 2026 to review its third quarter results, giving shareholders fresh information on operations, profitability, and recent share performance. Recent trading has been weak for Enovis, with the share price down 31.3% over the past 90 days and 33.3% year to date, and the 1 year total shareholder return down 40.4%. This suggests sentiment has cooled despite a small 1 day...
Enovis has seen its share price come under pressure in recent years, and that drop puts a spotlight on a simple question for investors who care about fundamentals. Do the cash flows that Enovis can generate over time line up with where the stock trades today? Over the past 5 years the share price has fallen 79.7%, which puts the focus squarely on whether the current valuation still reflects the cash the business can produce. Recent updates pointed to mid single digit organic sales growth and...
Detailed price information for Enovis Corp (ENOV-N) from The Globe and Mail including charting and trades.
Enovis (NYSE:ENOV) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. Benzinga APIs provide real-time access to earnings
Motley Fool Press Release.
Detailed price information for Enovis Corp (ENOV-N) from The Globe and Mail including charting and trades.
Enovis is back in focus for investors after a modest reset in its implied price target, with fair value in one model shifting from US$42.30 to about US$38.33. Analysts link this move to fresh thinking on the eCential Robotics acquisition, recent free cash flow trends, and the latest Q2 read through to growth plans and execution risk. As you read on, you will see how these moving parts shape the evolving Enovis story and what to watch next in the analyst narrative. Stay updated as the Fair...
Enovis (ENOV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Detailed price information for Enovis Corp (ENOV-N) from The Globe and Mail including charting and trades.
ENOV is set to acquire eCential Robotics to expand into orthopedic surgical robotics, though the deal is expected to pressure 2027 margins.
2026-09-02. The following slide deck was published by Enovis Corporation in conjunction with this event.
The orthopedics specialist aims to launch a knee robot in late 2028, followed by a shoulder robot in 2029.
Enovis (NYSE:ENOV) said it has entered a binding offer to acquire eCential Robotics, a developer of surgical robotics technology, in a move the orthopedic company said will expand its enabling-technology capabilities and accelerate its pathway into robotic surgery. Chief Executive Officer Damien Mc
Enovis (ENOV) has signed a binding offer to acquire eCential Robotics for 176 million euros ($204 mi
Enovis (ENOV) has an average rating of buy and mean price target of $41.58, according to analysts po
This is the newest page. Registered accounts read further back.